Walleye Capital LLC grew its stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 388.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 167,112 shares of the company's stock after buying an additional 132,869 shares during the period. Walleye Capital LLC owned 0.10% of BrightSpring Health Services worth $2,453,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. purchased a new stake in shares of BrightSpring Health Services in the first quarter valued at $54,638,000. FMR LLC boosted its holdings in BrightSpring Health Services by 17.2% in the third quarter. FMR LLC now owns 18,169,187 shares of the company's stock valued at $266,724,000 after acquiring an additional 2,664,582 shares during the last quarter. Magnetar Financial LLC boosted its holdings in BrightSpring Health Services by 46.9% in the second quarter. Magnetar Financial LLC now owns 1,188,302 shares of the company's stock valued at $13,499,000 after acquiring an additional 379,149 shares during the last quarter. Lisanti Capital Growth LLC acquired a new position in BrightSpring Health Services in the third quarter valued at $4,659,000. Finally, TD Asset Management Inc acquired a new position in BrightSpring Health Services in the second quarter valued at $2,308,000.
Insiders Place Their Bets
In other news, major shareholder Kkr Group Partnership L.P. bought 11,619,998 shares of the business's stock in a transaction on Wednesday, September 11th. The stock was purchased at an average cost of $11.13 per share, for a total transaction of $129,330,577.74. Following the completion of the transaction, the insider now directly owns 92,959,984 shares of the company's stock, valued at approximately $1,034,644,621.92. This trade represents a 14.29 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Analyst Ratings Changes
A number of brokerages recently weighed in on BTSG. BTIG Research lifted their target price on BrightSpring Health Services from $15.00 to $20.00 and gave the company a "buy" rating in a report on Thursday, October 3rd. Wells Fargo & Company boosted their price objective on BrightSpring Health Services from $17.00 to $21.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 27th. The Goldman Sachs Group cut their price target on BrightSpring Health Services from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Friday, August 9th. Guggenheim boosted their price target on BrightSpring Health Services from $15.00 to $18.00 and gave the stock a "buy" rating in a research note on Tuesday, October 1st. Finally, UBS Group boosted their price objective on BrightSpring Health Services from $16.00 to $20.00 and gave the company a "buy" rating in a report on Wednesday, October 30th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to data from MarketBeat, BrightSpring Health Services has a consensus rating of "Moderate Buy" and a consensus target price of $17.21.
Check Out Our Latest Report on BrightSpring Health Services
BrightSpring Health Services Stock Performance
BTSG stock traded down $0.27 on Wednesday, reaching $18.71. The company's stock had a trading volume of 340,332 shares, compared to its average volume of 1,461,043. BrightSpring Health Services, Inc. has a 52 week low of $7.85 and a 52 week high of $20.25. The company has a market capitalization of $3.26 billion and a P/E ratio of -73.00. The firm has a fifty day moving average of $16.92 and a two-hundred day moving average of $13.69. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its quarterly earnings data on Friday, November 1st. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by ($0.07). The business had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.72 billion. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. BrightSpring Health Services's revenue for the quarter was up 28.8% on a year-over-year basis. As a group, analysts predict that BrightSpring Health Services, Inc. will post 0.59 EPS for the current fiscal year.
BrightSpring Health Services Profile
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Further Reading
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.